Clinical Trials Directory

Trials / Completed

CompletedNCT04630015

Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth

Status
Completed
Phase
Study type
Observational
Enrollment
134 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

This study evaluates the effects of the Survivorship Wellness Group Program following active treatment, as well as to learn from Survivorship Wellness participants about their concerns regarding the current COVID-19 pandemic. This study may help to evaluate the impact of the survivorship program on patient well-being, provide evidence for use in grant application and publications, and ultimately inform the continued improvement of survivorship care.

Detailed description

PRIMARY OBJECTIVES: 1. To examine the feasibility and acceptability of implementing an interdisciplinary goal-setting clinical group program focused on domains of physical, psychological, and spiritual wellness for survivors of cancer at University of California San Francisco (UCSF). 2. To determine preliminary efficacy of the Survivorship Wellness intervention in regards to: 1. Increasing knowledge of and perceived confidence in execution of health behavior changes in domains of physical, emotional, and spiritual wellness for survivors of cancer. 2. Increasing quality of life. 3. Reducing symptoms of depression and anxiety. 4. Increasing physical activity. 3. To assess differences in patient wellbeing and in the impact of the Survivorship Wellness program during the period of COVID-19 and telehealth classes. OUTLINE: Patients complete surveys over 5-10 minutes at baseline (i.e. before participating in the program), and at 9 and 15 weeks follow up on the impact of COVID-19 on survivorship. Patients also complete a survey assessing how patients rate telehealth classes in the Survivorship Wellness program.

Conditions

Interventions

TypeNameDescription
OTHERSurvey AdministrationParticipants will complete study specific survey

Timeline

Start date
2020-08-31
Primary completion
2023-05-01
Completion
2023-05-01
First posted
2020-11-16
Last updated
2023-05-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04630015. Inclusion in this directory is not an endorsement.